Parametric Portfolio Associates’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$365K	Sell	20,981 -6,845	-25%	-$115K	﹤0.01%	3217
2021 Q4	$609K	Buy	27,826 +1,126	+4%	+$20.8K	﹤0.01%	2988
2021 Q3	$510K	Sell	26,700 -4,589	-15%	-$76.5K	﹤0.01%	3101
2021 Q2	$537K	Sell	31,289 -380	-1%	-$6.96K	﹤0.01%	3058
2021 Q1	$708K	Buy	31,669 +10,723	+51%	+$242K	﹤0.01%	3318
2020 Q4	$466K	Buy	20,946 +3,380	+19%	+$70.1K	﹤0.01%	3414
2020 Q3	$259K	Sell	17,566 -4,120	-19%	-$62.8K	﹤0.01%	3544
2020 Q2	$321K	Buy	21,686 +4,065	+23%	+$61.9K	﹤0.01%	3447
2020 Q1	$193K	Sell	17,621 -2,106	-11%	-$19.8K	﹤0.01%	3563
2019 Q4	$173K	Sell	19,727 -99	-0.5%	-$727	﹤0.01%	3773
2019 Q3	$148K	Buy	19,826 +1,512	+8%	+$13.8K	﹤0.01%	3771
2019 Q2	$171K	Buy	18,314 +5,162	+39%	+$37.6K	﹤0.01%	3767
2019 Q1	$69K	Buy	+13,152	New	+$75K	﹤0.01%	3855
2017 Q4	–	Sell	-34,310	Closed	-$401K	–	3939
2017 Q3	$401K	Sell	34,310 -2,255	-6%	-$27.6K	﹤0.01%	3545
2017 Q2	$511K	Buy	36,565 +13,911	+61%	+$159K	﹤0.01%	3360
2017 Q1	$311K	Sell	22,654 -473	-2%	-$4.91K	﹤0.01%	3414
2016 Q4	$166K	Sell	23,127 -464	-2%	-$5.08K	﹤0.01%	3630
2016 Q3	$358K	Buy	23,591 +298	+1%	+$3.92K	﹤0.01%	3340
2016 Q2	$229K	Buy	+23,293	New	+$319K	﹤0.01%	3556